Back
Cardiff Oncology, Inc. 10K Form
Sell
31
CRDF
Cardiff Oncology, Inc.
Last Price:
$1.83
Seasonality Move:
-3.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRDF News And Ratings
See the #1 stock for the next 7 days that we like better than CRDF
CRDF Financial Statistics
Sales & Book Value
| Annual Sales: | $593K |
|---|---|
| Cash Flow: | $-6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.66 |
| Price / Book: | 2.98 |
Profitability
| EPS (TTM): | -0.68650 |
|---|---|
| Net Income (TTM): | $-45.9M |
| Gross Margin: | $-311K |
| Return on Equity: | -74.77% |
| Return on Assets: | -59.8% |
Cardiff Oncology, Inc. Earnings Forecast
Key Cardiff Oncology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 15 years for CRDF is -52.45%.
-
The Selling, General & Administrative Expenses for CRDF have been equal to 2,398.65% of Gross Profit Margin.
-
The Research & Development expenses have been 5,957.67% of Revenue.
-
The Net Earning history of CRDF is -7,732.04% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 8 years.
Cardiff Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRDF |
| CUSIP: | 14147L |
| Website: | cardiffoncology.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 3.67 |
| Quick Ratio: | 3.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRDF Technical Analysis vs Fundamental Analysis
Sell
31
Cardiff Oncology, Inc. (CRDF)
is a Sell
Is Cardiff Oncology, Inc. a Buy or a Sell?
-
Cardiff Oncology, Inc. stock is rated a SellThe current Cardiff Oncology, Inc. [CRDF] share price is $1.98. The Score for CRDF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.